Bionor Immuno AS

Bionor Immuno is a multidisciplinary drug discovery company located in Skien, Norway. The major focus of the company is to develop effective peptide based immunotherapies, against infectious diseases for which there is currently no effective vaccine or where existing treatments are poorly effective. Bionor Immuno AS aims to develop its therapeutic products through phase II clinical trials. Phase III clinical trials, manufacturing and marketing of finished products will be done in co-operation with a licensing partner

Contact Details: P.O. Box 1823 Skien 3703 Norway Tel: 47 35 50 57 50 Fax: 47 35 50 57 01 Email: info@bionorimmuno.com WWW: www.bionorimmuno.com/

Recent Publications by Bionor Immuno AS:
Circular CCR5 peptide conjugates and uses thereof (WO2008074895). BACKGROUND: Several new strategies targeting HIV infection aim to inhibit...	27th October, 2009	Bionor Immuno AS, Klostergata 33, NO-3702 Skien, Norway.	Expert Opin Ther Pat. 2009 Sep;19(9):1323-8. DOI Direct Link
Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x). Delayed-type hypersensitivity (DTH) testing represents a simple in vivo...	13th May, 2006	Bionor Immuno AS, P.O. Box. 1823, NO-3703 Skien, Norway.	Vaccine. 2006 Mar 6;24(10):1543-50. Epub 2005 Nov 2. DOI Direct Link
Novel peptide-based HIV-1 immunotherapy. Therapeutic immunisation of human immunodeficiency virus type 1-infected...	14th July, 2004	Bionor Immuno AS, Stromdaljordet 4, PO Box 1823 Gulset, NO-3703 Skien,	Expert Opin Biol Ther. 2004 Mar;4(3):349-61. DOI Direct Link

BioNews Results for Bionor Immuno AS:
Researchers Find That Vacc-4x Therapeutic Peptide-Based HIV Vaccine Increases CD4 T-Cells in Chronically Infec	Yahoo! Canada:  Oct 21 2009 12:17PM Matching: bionor immuno
Bionor Immuno Welcomes Renowned Virologist Robert Redfield, MD to Its Clinical Advisory Board	Genetic Engineering News:  Oct 21 2009 10:03AM Matching: bionor immuno
Bionor Immuno Welcomes Renowned Virologist Robert Redfield, MD to Its Clinical Advisory Board	Individual.com:  Oct 19 2009 2:07PM Matching: bionor immuno
Bionor Immuno Welcomes Renowned Virologist Robert Redfield, MD to Its Clinical Advisory Board	Pharmacy Choice:  Oct 19 2009 9:15PM Matching: bionor immuno

Bionor Immuno AS Clinical Trials:
Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

Bionor Immuno AS Patents:
US Patent No.	Title
7097971	HIV-1 peptide, antigen, immunogenic composition, diagnostic method and immunoassay kit
7009037	Modified HIV-1gag p17 peptide and immunogenic composition
6706859	HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 710 times since April 2007, the link to the organisation's website has been followed 125 times

Recent Search Terms used to find this page: bionor imuno | bionor immuno | Bionor Immuno AS | bionor stromdaljordet skien | bionor immuno | bionor immuno | bionor | bionor norway | bionor norway | bionor clinical trials | .

Search for more companies in Skien

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Bionor Immuno AS